Colocalization of psoriasis and vitiligo treated with apremilast and narrowband ultraviolet B combination in an adolescent girl

Colocalization of psoriasis and vitiligo treated with apremilast and narrowband ultraviolet B combination in an adolescent girl

Coexistence of psoriasis and vitiligo in the same patient is a therapeutic challenge; several modalities have been tried with varying results. Apremilast is a PDE4 inhibitor used in psoriasis, while recent reports are highlighting its additional role in repigmentation of vitiligo. However, data are...

Full description

Bibliographic Details
Main Authors:	Trashita Hassanandani, Maitreyee Panda, Nibedita Patro, Debjit Kar
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2020-01-01
Series:	Indian Journal of Paediatric Dermatology
Subjects:	apremilast narrowband ultraviolet b psoriasis vitiligo
Online Access:	http://www.ijpd.in/article.asp?issn=2319-7250;year=2020;volume=21;issue=1;spage=70;epage=72;aulast=Hassanandani

Similar Items

Efficacy of targeted narrowband ultraviolet B therapy in Vitiligo
by: Imran Majid
Published: (2014-01-01)

Predictive Model for Response Rate to Narrowband Ultraviolet B Phototherapy in Vitiligo: A Retrospective Cohort Study of 579 Patients
by: Raúl Cabrera, et al.
Published: (2018-01-01)

Double-blind randomized trials once a week narrowband ultraviolet B (NB-UVB) phototherapy in vitiligo
by: Retno Dwi Utami, et al.
Published: (2018-06-01)

The effect of narrowband ultraviolet B phototherapy on serum folate level
by: Azar Shirzadian kebria, et al.
Published: (2021-03-01)

Clinico-Epidemiological Profile of Vitiligo Patients Receiving Narrowband Ultraviolet-B (NB-UVB) Treatment
by: Anasya Putri Ramadhina, et al.
Published: (2023-03-01)

Apremilast in paediatric dermatoses – A comprehensive review
by: Nibedita Patro, et al.
Published: (2022-01-01)

CLINICAL PROFILES OF VITILIGO WITH NARROWBAND UVB AND TOPICAL CORTICOSTEROID THERAPY AT DR. SOETOMO HOSPITAL
by: Sarah Fauzia, et al.
Published: (2020-01-01)

Characteristics and decreased VASI of vitiligo patients with NB-UVB phototherapy in Yogyakarta, Indonesia
by: Nabila Kirtti Pradipta, et al.
Published: (2023-05-01)

Pediatric scalp psoriasis: Therapeutic response to oral apremilast: A report of two cases
by: Anil Kumar Panda, et al.
Published: (2022-01-01)

The Efficacy and Safety of Narrowband Ultraviolet B Phototherapy in Geriatric Patients: A Retrospective Study
by: S N Yusharyahya, et al.
Published: (2019-01-01)

Evaluation of neopterin level and disease severity in patients with psoriasis vulgaris treated with narrowband UVB
by: Funda Kemeriz, et al.
Published: (2019-01-01)

Erythrodermic psoriasis treated with apremilast
by: John Arcilla, et al.
Published: (2016-09-01)

Recurrence of Melanoma after Starting Apremilast for Psoriasis
by: Thomas G. Salopek
Published: (2017-08-01)

Real-world insight on apremilast therapy in patients with plaque psoriasis: Indian experience
by: Abhishek De, et al.
Published: (2020-01-01)

Dramatic response of cutaneous, nail, and joint symptoms of psoriasis to apremilast
by: Meghana Bathina, et al.
Published: (2019-01-01)

Apremilast
by: Nihal Kundakçı
Published: (2022-04-01)

Dermoscopic changes in melanocytic nevi covered with both an opaque tape and sunscreen cream during narrowband ultraviolet B therapy
by: Derya Ök Kekeç, et al.
Published: (2018-04-01)

Acute Generalized Pustular Psoriasis Developed Resistance to Adalimumab Was Successfully Treated with Narrowband Ultraviolet B and Acitretin: A Case Report
by: Yang X, et al.
Published: (2022-11-01)

Evaluation of narrowband ultraviolet B phototherapy in patients with generalized lichen planus
by: Krishna P. P Arumilli, et al.
Published: (2018-01-01)

The Use of Apremilast in Psoriasis: An Indian Perspective on Real-World Scenarios
by: Rajagopalan M, et al.
Published: (2021-08-01)

Impact on quality of life in vitiligo patients treated with narrowband ultraviolet B phototherapy
by: Yatendra S Chahar, et al.
Published: (2018-01-01)

Real-world data on the efficacy and safety of apremilast in Japanese patients with plaque psoriasis
by: Chika Ohata, et al.
Published: (2019-05-01)

A Comparative Study of the Efficacy of Methotrexate versus Methotrexate with Apremilast in Moderate to Severe Chronic Plaque Psoriasis
by: Divyanshu Srivastava, et al.
Published: (2023-01-01)

Psoriasis In Patients With Active Lung Cancer: Is Apremilast a Safe Option?
by: Zoe Apalla, et al.
Published: (2019-10-01)

Experience in the treatment of psoriasis patients using Apremilast, a selective signalling pathway inhibitor
by: N. V. Kungurov, et al.
Published: (2019-04-01)

Apremilast: target synthetic drug for the treatment of psoriatic arthritis and psoriasis
by: Yu. L. Korsakova, et al.
Published: (2018-07-01)

Real-world efficacy and safety of apremilast monotherapy in the management of moderate-to-severe Psoriasis
by: Bela J Shah, et al.
Published: (2020-01-01)

Narrowband UVB phototherapy in pityriasis rosea
by: Vijayeeta Jairath, et al.
Published: (2015-01-01)

Efficacy of apremilast for psoriasis: a meta-analysis of randomized controlled studies
by: Yashu Liu, et al.
Published: (2022-09-01)

Fototerapia con radiación ultravioleta (UVB) de banda estrecha: una opción segura de manejo para vitiligo y otras dermatosis
by: Ricardo Flaminio Rojas López, MD, et al.
Published: (2010-01-01)

Peningkatan Jumlah Protein S100 pada Vitiligo setelah Terapi Narrowband-Ultraviolet B
by: Putri Hendria Wardhani, et al.
Published: (2018-09-01)

Apremilast in psoriasis patients with serious comorbidities: a case series and systematic review of literature
by: Aikaterini Tsentemeidou, et al.
Published: (2022-10-01)

Apremilast in psoriasis and beyond: Big hopes on a small molecule
by: T P Afra, et al.
Published: (2019-01-01)

Cost-effectiveness of apremilast in moderate to severe psoriasis in the United Kingdom
by: Anthony Bewley, et al.
Published: (2018-01-01)

Strict Anatomical Colocalization of Vitiligo and Elastolytic Granulomas
by: N. Merino de Paz, et al.
Published: (2010-02-01)

Strict anatomical co existence and colocalization of vitiligo and psoriasis – a rare entity
by: Neerja Puri, et al.
Published: (2013-04-01)

Apremilast survival and reasons for discontinuation in psoriasis: five-year experience from a Greek tertiary care centre
by: Elena Sotiriou, et al.
Published: (2022-05-01)

Clinical potential of apremilast in the treatment of psoriatic arthritis
by: Cauli A, et al.
Published: (2014-06-01)

Design and Application of a Nitrate Measurement System Based on a Narrowband Tunable Ultraviolet Light Source
by: Xingyue Zhu, et al.
Published: (2021-01-01)

Comparison amount of microphthalmia-associated transcription factor in vitiligo before and after narrowband-ultraviolet B therapy
by: M. Yulianto Listiawan, et al.
Published: (2019-03-01)